Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $156.0000 (2.56%) ($149.8100 - $161.2300) on Thu. Sep. 22, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.78% (three month average) | RSI | 71 | Latest Price | $156.0000(2.56%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SONN advances 17.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) QQQ(17%) IWC(16%) IWN(16%) SDY(16%) SKYY(16%) | Factors Impacting SONN price | SONN will decline at least -2.89% in a week (0% probabilities). VCSH(-26%) LQD(-20%) TLT(-18%) VCIT(-15%) CEMB(-14%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.89% (StdDev 5.78%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
5 Day Moving Average | $149.55(4.31%) | 10 Day Moving Average | $139.95(11.47%) | 20 Day Moving Average | $124.6(25.2%) | To recent high | 0% | To recent low | 55.4% | Market Cap | $1.435b | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |